Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Receivables - Net (2020 - 2025)

Historic Receivables - Net for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $5.4 million.

  • Rapid Micro Biosystems' Receivables - Net rose 4518.72% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 4518.72%. This contributed to the annual value of $7.5 million for FY2024, which is 3591.83% up from last year.
  • Per Rapid Micro Biosystems' latest filing, its Receivables - Net stood at $5.4 million for Q3 2025, which was up 4518.72% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Receivables - Net ranged from a high of $7.5 million in Q4 2024 and a low of $3.1 million during Q2 2021
  • For the 5-year period, Rapid Micro Biosystems' Receivables - Net averaged around $4.8 million, with its median value being $5.0 million (2021).
  • As far as peak fluctuations go, Rapid Micro Biosystems' Receivables - Net tumbled by 1612.28% in 2023, and later surged by 4518.72% in 2025.
  • Rapid Micro Biosystems' Receivables - Net (Quarter) stood at $5.0 million in 2021, then grew by 7.27% to $5.4 million in 2022, then increased by 3.04% to $5.5 million in 2023, then skyrocketed by 35.92% to $7.5 million in 2024, then decreased by 27.78% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $6.0 million for Q2 2025, and $4.5 million during Q1 2025.